Medicolegal and ethical issues in genetic cancer syndromes

Seminars in Surgical Oncology

Volumn 18, Issue 4, 2000, Pages 339-346

  Anderlik, Mary R ^a   Lisko, Elaine A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Breast neoplasms surgery prevention and control; Confidentiality; Expert testimony; Genetic counseling; Genetic predisposition to disease; Genetic screening; Health Insurance Portability and Accountability Act; Health insurance legislation and jurisprudence; Human Genome Project legislation and jurisprudence; Informed consent; Insurance selection bias; Legal liability; Medical ethics; Medical records; Privacy; Risk assessment; United States

Indexed keywords

ARTICLE; CANCER RISK; CONFIDENTIALITY; HUMAN; HUMAN CELL; INFORMED CONSENT; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; UNITED STATES;

GENETICS AND REPRODUCTION; LEGAL APPROACH;

CONFIDENTIALITY; ETHICS, MEDICAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INSURANCE COVERAGE; LIABILITY, LEGAL; NEOPLASMS; PATIENT ADVOCACY; TRUTH DISCLOSURE; UNITED STATES;

EID: 0034102743     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(200006)18:4<339::AID-SSU9>3.0.CO;2-K     Document Type: Article

References (40)

1. See, e.g., Convention on Human Rights and Biomedicine, opened for signature Apr. 4, 1997, entered into force Jan. 1, 1999, E.T.S. No. 164, Art. 5,12.
2. Mulholland WF II, Jaeger AS: Genetic privacy and discrimination: a survey of state legislation. Jurimetrics 1999;39:317-326.
3. See, e.g., N.J. Rev. Stat. § 10:5-46 (1998); N.M. Stat. Ann. § 24-21-5 (1998).
4. N.Y. Civ. Rights Law § 79-1 (McKinney 1999).
5. See, e.g., Colo. Rev. Stat. Ann. § 10-3-1104.7(12) (1999); Nev. Rev. Stat. Ann. § 629.201 (Michie 1997); N.M. Stat. Ann. § 24-21-6 (1998).
6. 42 U.S.C.A. §§ 300gg(b)(1)(B), 300gg-1(1)(F) (West Supp. 1999).
7. Rothenberg KH: Breast cancer, the genetic "quick fix," and the Jewish community. Health Matrix 1997;7:97-124.
8. 42 U.S.C.A. § 12112(a) (West 1995).
9. 42 U.S.C.A. §§ 12111(8), 12102(2) (West 1995).
10. 2 EEOC Compl. Man. (CCH) ¶ 6880 (March 14, 1995).
11. Rothstein MA: Genetic privacy and confidentiality: why they are so hard to protect. J Law Med Ethics 1998;26:198-203.
12. Rothstein MA, Gelb BD, Craig SG: Protecting genetic privacy by permitting employer access only to job-related employee medical information: analysis of a unique Minnesota law [Review]. Am J Law Med 1998;24:399-416.
13. See, e.g., La. Rev. Stat. Ann. § 23:352 (West 1998).
14. Tex. Labor Code Ann. §§ 21.401-.402 (Vernon's 1999).
15. N.J. Stat. Ann. § 10:5-12 (West 1999).
16. McGoodwin WL: Genetic testing in life and disability insurance: a new challenge for public policy. Fall Brief 1998;28:24-31.
17. Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues. Am J Hum Genet 1995;56:327-331.
18. La. Rev. Stat. Ann. § 22:213.7(A)(8) (West 1999); Fla. Stat. Ann. § 627.4301 (1999); Mo. Ann. Stat. § 375.1300 (Vernon's 1999); 1999 Mont. Laws Ch. 334 (H.B. 111); Okla. Stat. Ann. tit. 36, § 3614.1 (1998); Tenn. Code Ann. § 56-7-2706 (1998).
19. Or. Rev. Stat. § 659.715 (1997); Del. Code Ann. tit. 16, § 1225 (1999); N.J. Stat. Ann. § 10:5-46 (1998).
20. See, e.g., Colo. Rev. Stat. Ann. § 10-3-1104.7(1)(a) (1999); Fla. Stat. Ann. § 760.40 (1999); Ga. Code Ann. § 33-54-1 (1998); La. Rev. Stat. Ann. § 22:213.7(E) (West 1999).
21. Moore v. Regents of University of California, 793 P.2d 479 (Cal. 1989), cert, denied, 499 U.S. 936 (1991).
22. Mont. Code Ann. § 50-16-529 (1999); Wash. Rev. Code Ann. § 70.02.050 (1999).
23. Pate v. Threlkel, 661 So.2d 278 (Fla. 1995).
24. Safer v. Estate of Pack, 291 N.J.Super. 619, 677 A.2d 1188 (N.J. Super. Ct. App. Div. 1996), cert. denied, 683 A.2d 1163 (N.J. 1996).
25. Holtzman NA, Watson MS (eds): ¶Promoting safe and effective genetic testing in the United States: final report of the Task Force on Genetic Testing.¶ Baltimore: Johns Hopkins University Press; 1998.
26. Cooper EB: Testing for genetic traits: the need for a new legal doctrine of informed consent. Md L Rev 1999;58:346-422.
27. Matthies v. Mastromonaco, 160 N.J. 26, 733 A.2d 456 (N.J. 1999).
28. Backlund v. University of Washington, 137 Wash.2d 651, 975 P.2d 950 (Wash. 1999) (en banc).
29. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. Adopted on February 20, 1996. J Clin Oncol 1996;14:1730-1740.
30. Andrews LB: Torts and the double helix: malpractice liability for failure to warn of genetic risks. Hous L Rev 1992;29:149-184.
31. Vt. Stat. Ann. tit. 18, § 9332 (1998).
32. Giardiello FM, Brensinger JD, Petersen GM, et al: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-827.
33. Weiss R: Genetic testing's human toll; in unregulated field, errors can upend lives and mean unneeded surgery. Washington Post 1999 21 July; Sect. A:1.
34. Lopez MJ, Porter KA: The current role of prophylactic mastectomy [Review]. Surg Clin North Am 1996;76:231-242.
35. Brown v. Dibbell, 595 N.W.2d 358 (Wis. 1999).
36. Borgen PI, Hill AD, Tran KN, et al: Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 1998;5:603-606.
37. Johnson M: Grim family history of breast cancer leads woman to preemptive surgery. Providence Sunday Journal 1998 17 May; Sect. A:1.
38. Katskee v. Blue Cross/Blue Shield of Nebraska, 245 Neb. 808, 515 N.W.2d 645 (Neb. 1994).
39. Wolf D: Who should pay for "experimental" treatments? Breast cancer patients v. their insurers. Am Univ Law Rev 1995;44: 2029-2107.
40. Anderson v. HMO Nebraska, Inc., 1993 WL 61839 (Neb. Ct. App. 1993), rev'd, 244 Neb. 237, 505 N.W.2d 700 (Neb. 1993) (reversal on jurisdictional grounds; no discussion of contract interpretation).